(Q34278437)
Statements
1 reference
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study (English)
1 reference
Paul S Gaynon
1 reference
Yoav H Messinger
1 reference
Richard Sposto
1 reference
Jeannette van der Giessen
1 reference
Elena Eckroth
1 reference
Jemily Malvar
1 reference
Bruce C Bostrom
1 reference
Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium
1 reference
31 May 2012
1 reference
1 reference
120
1 reference
2
1 reference
285-290
1 reference
Identifiers
1 reference
1 reference